ArginMax Clinical Research for Men

ArginMax for Men Research

The Daily Wellness Company, the makers of ArginMax, is committed to supporting scientific research. The Company has taken a methodical and clinical approach toward the development of ArginMax in order to establish the highest level of credibility and consumer trust.

Several physician-directed studies have been conducted on ArginMax, including a recently completed double-blind placebo-controlled study on men with mild to moderate erectile dysfunction — the first of its kind in the sexual health category. View an abstract of this double-blind placebo-controlled study.

In a pilot study of ArginMax conducted by physicians from the University of Hawaii and Albany Medical College, men diagnosed with mild to moderate erectile dysfunction were placed on four weeks of ArginMax supplementation. At the conclusion of the study, 89 percent improved in the ability to maintain an erection during intercourse, while 75 percent improved in satisfaction with overall sex life.

Other multi-center clinical studies include those evaluating the role of ArginMax designed for women in female sexual fitness.

Clinical Research
Clinical research on ArginMax has received invitation for presentation at the following international medical conferences:

• American Urological Association’s Mid-Atlantic Section Meeting October 1999
• American Urological Association’s Western Section Meeting September 1999
• 14th International Congress of Sexology Hong Kong, August 1999
• Hong Kong Academy of Medicine First International Congress Hong Kong, China, November 26-29, 1998
• 24th International Congress of Internal Medicine Lima, Peru, November 3-7, 1998
• Asian Clinical Trials Conference Hong Kong, China, October 25-27, 1998
• American Urological Association – New York Section Prague, Czech Republic, October 10-17, 1998
• European Academy of Quality of Life and Longevity Medicine Brussels, Belgium, September 24-26, 1998
• 4th Asian Congress of Urology Singapore, Republic of Singapore, September 17-20, 1998

Study Summary

Study on the Effects of ArginMax, A Natural Dietary Supplement for Enhancement of Male Sexual Function T. Ito M.D., K. Kawahara M.D., A. Das M.D. FACS, W. S. M.D.

Summary: We report results from a clinical study examining the effects of ArginMax on male sexual function in a group of men diagnosed with mild to moderate erectile dysfunction. ArginMax (The Daily Wellness Company) is a dietary supplement consisting of a highly standardized combination of ginkgo biloba, Korean ginseng, American ginseng, L-arginine, vitamins A, C, E, B6, and B12, folate, thiamin, riboflavin, niacin, biotin, pantothenic acid, zinc, and selenium.

In our pilot study, twenty-five (25) participants enrolled through a urology clinic were evaluated over a 4-week period while on a twice-a-day regimen of ArginMax. Subjects were enrolled consecutively. The study was open to all individuals previously diagnosed with mild to moderate erectile dysfunction. Ages ranged from 40-77. Subject progress was measured using a Sexual Function Questionnaire (SFQ) consisting of validated sexual function and quality of life scoring measures. Following four weeks of a daily regimen of ArginMax, twenty-one (21) subjects that completed the regimen were evaluated.

88.9% of the subjects experienced improvement in ability to maintain an erection during intercourse.

75.0% of the subjects experienced improvement in satisfaction with their overall sex life.

No significant reports of side effects including headaches, nausea, stomach upset, changes in blood pressure, disturbed vision, chest pain, or dizziness were noted.

Several studies report on the effectiveness of various individual ingredients contained in ArginMax. Below is a list of journals and summaries of the studies published by them:

Journal of Urology
September 1997
Moody JA, et al

There is a reasonable basis for using dietary supplementation with L-arginine to improve male sexual function.

Circulation
June 1998
Lerman A., et al,
(American Heart Association, Inc.)

This Mayo Clinic study demonstrated that oral supplementation with L-arginine can actually improve small-vessel circulatory function and be used as a therapeutic option for patients with non-obstructive coronary artery disease.

Biochemistry Biophysics Research Communication
May 1997
Washer TC, et al

Nitric oxide is a messenger molecule in our body that controls erections. Oral supplementation with L-arginine increases the production of nitric oxide.

International Journal of Impotence Research
September 1995
Choi HK, et al

Korean ginseng significantly improves erectile function.

Clinical Experimental Pharmacology and Physiology
August 1996
Chen Xiu

Panax ginseng (which includes American and Korean ginseng varieties) produces an overall improvement in nitric oxide production throughout the body, resulting in better erectile function and cardiovascular function.

British Journal of Pharmacology
May 1995
Lee TJ, et al

Ginsenosides, one of the active ingredients in Panax ginseng, increases nitric oxide release and erections.

Get Our Blogs In Your Inbox Each Month!